Page 2 - Pharma Firms

Pharma companies seek stability in Trump's fight against high drug cost

Companies including Johnson & Johnson and Bayer Corp. decreased their spending from the first quarter

Now, Indian pharmaceutical majors also face the African challenge

Cipla and Aurobindo among major companies whose March quarter sales in the institutional segment fell close to 50%

Niche players bet on bringing in therapies to India from abroad

Sundyota Numandis is bringing in global formulations in probiotics, nutraceuticals, hytopharmaceuticals through licensing route

Indian pharma firms renew focus; Dr Reddy's, Cipla eye $100-bn China market

DRL looking to introduce anti-cancer drugs, while Cipla, Wockhardt planning to launch core therapies

Pharma companies focus on limited competition drugs for the US market

Companies are sharing their strategy at JP Morgan Conference

API cost increase to hit pharma firms' profit

In the past two months, the prices of API imported from China have gone up by 30-50 per cent

Four pharma firms face US price-fixing charge

US lawmakers turn the heat on Dr Reddy's, Glenmark, Sun Pharma and Emcure